Clinical Trial Update: Umbilical Cord Mesenchymal Stem Cells Transplantation in the Treatment of Bronchopulmonary Dysplasia [Phase 1]

View source ↗

Summary

Phase 1 study examining transplantation of umbilical cord-derived mesenchymal stem cells for bronchopulmonary dysplasia has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bronchopulmonary Dysplasia

Drugs mentioned

• Umbilical cord-derived mesenchymal stem cells (mesenchymal stem cells)

Snippet

Sponsor: Vinmec Research Institute of Stem Cell and Gene Technology | Conditions: Bronchopulmonary Dysplasia | Phase 1 | Status: COMPLETED